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Positive Geometric Vascular Remodeling Is Seen After
Catheter-Based Radiation Followed by Conventional Stent
Implantation but Not After Radioactive Stent Implantation
I. Patrick Kay, MBChB; Manel Sabate´, MD; Marco A. Costa, MD; Ken Kozuma, MD;
Mariano Albertal, MD; Willem J. van der Giessen, MD, PhD; Alexander J. Wardeh, MD;
Jurgen M.R. Ligthart, BSc; Veronique M.A. Coen, MD;
Peter C. Levendag, MD, PhD; Patrick W. Serruys, MD, PhD
Background—Recent reports demonstrate that intracoronary radiation affects not only neointimal formation but also
vascular remodeling. Radioactive stents and catheter-based techniques deliver radiation in different ways, suggesting
that different patterns of remodeling after each technique may be expected.
Methods and Results—We analyzed remodeling in 18 patients after conventional stent implantation, 16 patients after
low-activity radioactive stent implantation, 16 patients after higher activity radioactive stent implantation, and, finally,
17 patients who underwent catheter-based radiation followed by conventional stent implantation. Intravascular
ultrasound with 3D reconstruction was used after stent implantation and at the 6-month follow-up to assess remodeling
within the stent margins and at its edges. Preprocedural characteristics were similar between groups. In-stent neointimal
hyperplasia (NIH) was inhibited by high-activity radioactive stent implantation (NIH 9.0 mm3) and by catheter-based
radiation followed by conventional stent implantation (NIH 6.9 mm3) compared with low-activity radioactive stent
implantation (NIH 21.2 mm3) and conventional stent implantation (NIH 20.8 mm3) (P50.008). No difference in plaque
or total vessel volume was seen behind the stent in the conventional, low-activity, or high-activity stent implantation
groups. However, significant increases in plaque behind the stent (15%) and in total vessel volume (8%) were seen in
the group that underwent catheter-based radiation followed by conventional stent implantation. All 4 groups
demonstrated significant late lumen loss at the stent edges; however, edge restenosis was seen only in the group
subjected to high-activity stent implantation and appeared to be due to an increase in plaque and, to a lesser degree, to
negative remodeling.
Conclusions—Distinct differences in the patterns of remodeling exist between conventional, radioactive, and catheter-
based radiotherapy with stenting. (Circulation. 2000;102:1434-1439.)
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In our enthusiasm to control vessel recoil and remodelingafter balloon angioplasty (BA), stent implantation has
become increasingly popular. With conventional stenting, we
have eliminated recoil and remodeling as components of the
restenotic process. However, this has been at the cost of
exacerbating neointimal proliferation secondary to chronic
vessel wall irritation, leading to in-stent restenosis.1,2
Intracoronary radiation has been developed in an attempt to
decrease restenosis after BA and stent implantation. Two
parallel technologies, one using radioactive stents3–7 and the
other using catheter-based radiation,8–10 have been the subject
of both animal and human studies. Given the different dose
rates and total doses delivered by each method, one may
intuitively expect different patterns of remodeling subsequent
to each approach.
Whereas the effect of catheter-based radiation after BA on
vascular remodeling has been described,11 the response of the
arterial wall to catheter-based radiation and subsequent stent
implantation has not been described. Preliminary studies have
reported the effect at the stent edge after radioactive stent
implantation.4 However, these reports did not encompass the
response behind the stent in the arterial wall.
The aim of the present study was to describe the response
of the coronary artery to radiation and stenting by examining
the stent and its edges after radioactive stent implantation and
also after catheter-based radiation with stent implantation.
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Methods
Patient Selection
We analyzed geometric vascular remodeling in 4 groups of patients:
(1) LA group, those who had undergone implantation of 32P-emitting
radioactive stents at activity levels of 0.75 to 1.5 mCi (Isostent Inc);
(2) HA group, those who had undergone implantation of 32P
radioactive stents at activity levels of 6.0 to 12 mCi (Isostent Inc); (3)
CBS group, those who had undergone conventional stent implanta-
tion after suboptimal BA (clinically significant dissection or residual
stenosis .30%) and catheter-based radiation; and (4) C group, those
who had undergone conventional stent implantation after suboptimal
BA .
Stents analyzed were from patients with single–native-vessel
coronary artery disease, normal left ventricular function, and objec-
tive evidence of ischemia. All groups were matched for patient
baseline characteristics, vessel size, lesion, and stent length. Stents
placed in the ostial position or adjacent to major side branches, such
that the stent edges were unable to be analyzed, were excluded from
analysis. Only patients who had completed 6-month angiographic
and intravascular ultrasound (IVUS) follow-up were included.
Implantation Technique
The same group of cardiologists, using a similar technique, im-
planted all stents. Predilation of the lesion was performed, followed
by stent implantation with use of either a premounted stent or the
Johnson & Johnson delivery system (Johnson & Johnson Interven-
tional Systems Co). A balloon shorter than the stent was then
selected, and high-pressure balloon inflation was performed within
the stent to ensure good stent apposition. Intravascular ultrasound
was used to ensure optimal stent deployment.
Medication
Patients received 250 mg aspirin and 10 000 IU heparin at the
initiation of the procedure, and the activated clotting time was
maintained at .300 seconds. All patients received aspirin (80 mg
daily) indefinitely and ticlopidine (250 mg BID) for 2 weeks (C
group) or clopidogrel (75 mg daily) for 12 weeks (LA, HA, and CBS
groups) after stent implantation.
Radioactive Stents
The BX stent (Isostent Inc) was the only radioactive stent implanted
in this trial. It was 15 mm in length and available in diameters of 3.0
and 3.5 mm. The BX stent was made radioactive by 32P. The initial
activity of the stents was measured; thereafter, it was calculated at
the date on which the activity had decreased to 0.75 to 1.5 mCi or 6
to 12 mCi, levels suitable for implantation.
Catheter-Based Radiation Delivery System
The Beta-Cath System (Novoste Corp) was used to deliver localized
b-radiation (90Sr/90Y) to a depth of 2 mm from the center of the
TABLE 1. Clinical Characteristics
Groups
C LA HA CBS
Patients, n 18 16 15 17
Age, y 58 (42–76) 60 (43–74) 59 (42–75) 57 (45–74)
Male, % 70 66 70 60
Prior MI, % 40 40 45 40
Unstable angina, % 60 50 65 55
Smoking, % 40 55 40 40
Hypercholesterolemia, % 60 62 65 55
Family history, % 33 42 30 40
Hypertension, % 40 42 30 33
Diabetes, % 5 5 10 6
Age values are mean (range). MI indicates myocardial infarction.
TABLE 2. Procedural Characteristics
Groups
C LA HA CBS
Vessels, n
LAD 10 9 9 9
LCx 4 3 3 4
RCA 4 4 3 4
Lesion length, mm 9.663.3 12.163.8 10.163.3 11.964
Stent length, mm 14.663.8 15.0 15.0 15.264.1
Balloon length after implantation, mm 14.863.4 14.462.8 14.162.6 15.163.6
Final balloon size, mm 3.260.4 3.160.6 3.460.5 3.260.5
Max inflation pressure 1 11.562.4 11.662.6 10.262.8 12.262.6
Max inflation pressure 2 14.663.2 15.262.4 15.861.7 15.463.3
Balloon-to-artery ratio 1.0460.05 1.1260.06 1.1060.06 1.1260.05
Values are mean6SD. LAD indicates left anterior descending coronary artery; LCx, left circumflex coronary artery;
RCA, right coronary artery; Max inflation pressure 1, balloon at time of stent implantation; and Max inflation pressure
2, balloon inflation within stent.
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source at the site of coronary intervention. The device consisted of 3
components: (1) the transfer device that stored the radiation source
train and allowed the positioning of these sources within the catheter;
(2) the delivery catheter, which was a 5F multilumen over-the-wire
noncentered catheter that used saline solution to send and return the
radiation source train; and (3) the radiation source train, which
consisted of a series of 12 independent cylindrical seeds that
contained the radioisotope 90Sr sources and was bordered by 2 gold
radiopaque markers separated by 30 mm. Other device and proce-
dural details have been previously published by this group.11
Definitions
Stent Edges
Stent edges were defined as those volumes axially 5 mm proximal
and distal to the final stent strut. An edge restenosis was defined as
an angiographic restenosis .50% at 6-month follow-up located at
either stent edge. An edge effect was defined as any stent-edge
renarrowing.
Patients with balloon-injured edges that failed to receive radiation
in the catheter-based radiation group were excluded. In other words,
no stents implanted in areas of geographical miss were included in
the present study.
IVUS Image Acquisition Analysis
After the final balloon inflation and administration of intracoronary
nitrates, ECG-gated IVUS pullback was performed. This was re-
peated at the 6-month follow-up.
The segment subjected to 3D reconstruction was examined with a
mechanical IVUS system (ClearView, CVIS) with a sheath-based
IVUS catheter incorporating a 30-MHz single-element transducer
rotating at 1800 rpm. The IVUS transducer was withdrawn through
the stationary imaging sheath by an ECG-triggered pullback device
with a stepping motor.12 IVUS images coinciding with the peak of
the R wave, which eliminates the artifacts caused by the movement
of the heart during the cardiac cycle, were acquired. After each
image acquisition, the transducer was withdrawn 0.2 mm to acquire
the next image coincident with the R wave. The ECG-gated image
acquisition and digitization was performed by a workstation de-
signed for the 3D reconstruction of echocardiographic images12
(EchoScan, Tomtec). A Microsoft Windows–based contour detec-
tion program, developed at the Thoraxcenter, Rotterdam, was used
for the automated 3D analysis of up to 200 IVUS images.13 The
feasibility, reproducibility, and interobserver and intraobserver vari-
ability of this system have been previously validated in clinical
protocols.11
Quantitative IVUS Analysis
At the stent edges, the area encompassed by the lumen-intima and
media-adventitia boundaries defined the luminal volume (LV) and
the total vessel volume (TVV), respectively. The difference between
LV and TVV defined the plaque volume. TVV, stent volume,
neointimal hyperplasia (NIH), plaque behind the stent (TVV2stent
volume), and LV were obtained within the axial boundaries of the
stent.
The assessment of TVV in stented patients has previously been
reported.14 Although in the previous report the delineation of TVV
was not possible in some patients because of stent shadowing, in the
present study the delineation of the TVV boundary was possible in
all stented patients. When the TVV boundary was not visible in a
single cross-sectional view, the computer extrapolated it from the
contours of the previous and subsequent cross sections. In addition,
the use of 3D reconstruction with multiple longitudinal views
facilitates the visualization of vessel structures outside the stent.
Statistical Analysis
Quantitative data are presented as mean6SD. Volumetric data
derived from the 3D reconstruction of the IVUS imaging were
compared immediately after treatment and at follow-up by the
2-tailed paired Student t test. Comparison between groups was
performed by 1-way ANOVA. A value of P,0.05 was considered
statistically significant.
The Medical Ethical Committee of the University Hospital Rot-
terdam approved the study, and all patients provided written in-
formed consent before the procedure.
TABLE 3. Volumes for Edge Proximal and Distal to Stent (10-mm Length)
Group
Edge, mm3
LV TVV Plaque
Post F/UP Post F/UP Post F/UP
C 67.7618.9 58.3619.3* 124.4632.6 116.5634.1* 56.7622.6 58.2623.1
LA 75.2639.0 67.3634.4* 126.6658.0 116.4649.0* 51.4624.5 49.1621.0
HA 74.9623.0 63.0623.7* 126.2644.9 117.6646.2* 51.3616.4 54.6616.1
CBS 72.6627.7 61.1626.3* 133.2648.5 138.9646.5† 60.6626.1 77.8628.6*†
Values are mean6SD. Post indicates baseline; F/UP, follow-up.
*P,0.05 vs Post (within-group comparison); †P,0.05 for between-group comparison (ANOVA).
TABLE 4. Volumes for Stent
Group
Stent, mm3
LV TVV PBS
Post F/UP Post F/UP Post F/UP NIH
C 113.9629.7 92.8628.7* 256.1673.2 257.3667.4 142.2654.1 143.7649.4 20.8611.5
LA 127.3642.6 105.5640.1* 266.6696.5 264.5698.3 139.3659.1 137.8663.7 21.2612.1
HA 122.4620.0 111.7624.3* 267.8666.9 265.3665.1 145.4649.1 144.6645.3 9.068.6†
CBS 128.6641.3 121.8641.6* 258.9673.6 278.0689.8* 130.3634.2 149.3649.8* 6.966.6†
Values are mean6SD. Post indicates baseline; F/UP, follow-up; and PBS, plaque behind the stent. No significant difference between
groups was seen at baseline (Post).
*P,0.05 vs Post (within-group comparison); †P,0.05 for between-group comparison (ANOVA).
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Results
Baseline Characteristics
Eighteen patients were enrolled in the conventional group (C
group), 16 patients were enrolled in both the 0.75- to 1.5-mCi
and the 6.0- to 12-mCi radioactive stent groups (LA and HA
groups, respectively), and 17 patients were enrolled in the
group subjected to catheter-based radiation plus a stent (CBS
group). In the C group, 10 ACS Multi-Link (Guidant Corp)
and 8 NIR (new intravascular rigid-flex stent; Boston Scien-
tific/Scimed) stents were implanted, and in the CBS group, 8
NIR and 9 ACS Multi-Link stents were implanted. Baseline
characteristics are similar between all groups and are de-
scribed in Table 1. Lesion and procedural characteristics are
described in Table 2. No statistically significant differences
were seen between groups in the parameters described in
Table 2. Comparisons of volumetric data measured at the
stent edges and within the margins of the stent are presented
in Tables 3 and 4.
In-Stent Inhibition of NIH
Intrastent NIH was decreased after high-activity radioactive
stent implantation and catheter-based radiation followed by
conventional stent implantation (P50.008). Lower activity
radioactive stents had an effect similar to that of conventional
stent implantation (see Table 4 and Figure 1).
Behind Stent
The C, LA, and HA groups demonstrated an absence of
remodeling behind the stent, with no significant changes in
TVV or plaque volumes. This is in contrast to the CBS group,
which demonstrated a significant increase in plaque (imme-
diately after treatment versus follow-up, 15%; P50.002) and
an increase in TVV (after treatment versus follow-up, 8%;
P50.003). Intergroup comparison showed that this change
was significant (Table 4, P50.01). Further comparisons of
changes within and between groups are demonstrated in
Figure 1. No chronic recoil of the stent was seen in any group.
Stent Edge
No significant difference between groups was seen at base-
line (after stent implantation). All groups demonstrated late
lumen loss at the stent edges. At the stent edges, remodeling
is similar in the C and LA groups. In these groups, there is
evidence of a decrease in TVV, with little change in plaque as
a cause of late lumen loss (Figure 2). In the HA group, a
target segment restenosis (angiographically .50%) was ob-
served in 7 patients at the stent edges. This was more
common at the proximal edge (in 6 of 7 patients). The major
mechanism of such a restenosis appears to be due to an
increase in plaque at the stent edge. In nonrestenotic patients,
the edge effect appears to be due to a decrease in TVV and,
to a lesser degree, an increase in plaque (Figure 3).
In the CBS group, the edge effect is largely due to an
increase in plaque, with no negative remodeling seen
(P50.045 for plaque increase in CBS versus LA, HA, and C
groups). No patient with edge restenosis after catheter-based
radiation was seen in our series of patients.
Stent Activity and Dose Prescribed
Mean stent activity at implantation (LA group) was 1.160.3
mCi. Mean stent activity at implantation (HA group) was
8.661.6 mCi. For the CBS group, the mean dose prescribed
was 16.762.0 Gy.
Discussion
The development of NIH within the stent witnessed at the
6-month follow-up is well appreciated15; however, the
Figure 1. Remodeling within margins of stent. PBS indicates
plaque behind the stent. *P,0.05 for values immediately after
treatment vs follow-up; †P,0.05 for values between groups.
Figure 2. Changes in volumes at stent edge. PV indicates
plaque volume. *P,0.05 for values immediately after treatment
vs follow-up; †P,0.05 for values between groups; and ‡P5NS
for DLV (all groups) and DPV (C, LA, and HA groups).
Figure 3. High-activity (6.0- to 12.0-mCi) stents. Restenotic
edges are compared with nonrestenotic edges. D indicates
change in volume (immediately after treatment vs follow-up).
*P,0.05 for values immediately after treatment vs follow-up.
Note greater lumen loss seen in restenotic group. This loss was
caused by increase in plaque (P,0.05) and a less profound
decrease in TVV (P,0.05). DTVV is similar in both groups.
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changes that occur at the stent edges or indeed behind the
stent struts have not been the focus of attention until recent-
ly.4 The present study is the first to describe the difference in
vascular remodeling seen after radioactive stent implantation
and catheter-based radiation plus stenting with the use of
modern conventional stents as a benchmark. The key findings
are as follows: (1) The degree of inhibition of NIH was
similar in the HA and CBS groups. (2) There was no
significant remodeling behind the stent after conventional or
radioactive stent implantation; however, the CBS group
demonstrated an increase in plaque behind the stent and in
TVV. (3) At the stent edge, 3 patterns of remodeling are seen
at the 6-month follow-up: first, a shrinkage in TVV and LV
was noted in the C and LA groups. These 2 subgroups were
not associated with stent edge restenosis in this series. After
high-activity stent implantation, a pattern similar to conven-
tional and low-activity stent implantation is seen in those
edges that remain nonrestenotic; however, in the restenotic
edges, plaque increase is the major contributor to lumen loss.
In the CBS group, a lumen loss similar to that found in the
other groups is seen; however, this occurs secondary to a
relatively greater increase in plaque, without loss in TVV.
Neointimal Hyperplasia
In the present study, neointimal formation was inhibited after
higher dose radioactive stent implantation and after catheter-
based radiation plus stenting. The present study is in contrasts
to the recent study by Carter et al,16 who used 32P stents in the
porcine model, but is in keeping with earlier studies of
Hehrlein et al,6 who used the rabbit model, and recent reports
by Albiero et al,4 who noted a dose-dependent inhibition of
NIH.
Mechanism of Remodeling Behind the Stent
Catheter-Based Radiation
After conventional and radioactive stent implantation, little
positive or negative remodeling is witnessed behind the stent.
In stark contrast to this is the increase in plaque behind the
stent and TVV seen after catheter-based radiation and stent-
ing. Part of the key to understanding this process may be
acquired from understanding the healing process after BA.
Wilcox and colleagues17,18 describe the presence of early
proliferation of myofibroblasts expressing contractile pro-
teins in the adventitia surrounding the porcine coronary artery
after BA. Tracing studies have indicated that the same cells
migrate and form part of the neointima. Wilcox and col-
leagues hypothesize that the adventitial myofibroblasts con-
strict the artery at the angioplasty site in much the same way
as myofibroblasts participate in scar retraction in dermal
healing. The source of these myofibroblasts may be distant to
the immediate site of injury, including pericardial, adipose,
and intramyocardial layers.19
Radiation treatment of porcine coronary arteries after BA
upregulates p21 synthesis in adventitial cells, especially
myofibroblasts. Such induction is dose dependent and is
sustained for at least 7 days after radiation. Additionally,
radiation inhibits the expression of growth factors, reduces
the proliferation of adventitial myofibroblasts, and decreases
the production of a-actin by the adventitial myofibroblasts,
preventing the formation of the myofibroblast scar around the
angioplasty site and negative vascular remodeling.17,20 Data
from Fareh and et al 21 suggest that inhibition of migration but
not of cellular proliferation may occur at lower doses of
radiation. Therefore, cells may remain in situ, unable to
migrate but able to grow in the presence of a weakened
external elastic membrane. After 1 week, the effect of the
radiation diminishes, and cellular proliferation, possibly as a
reaction to the presence of the stent, continues behind the
stent in the context of positive vascular remodeling. In our
cohort of patients, no cases of stent malapposition were seen
at follow-up, although our group has described this as a risk
of ongoing positive vascular remodeling.22,23 A further con-
cept to be explored is that relating to the sharp drop-off in
radiation seen with the b-radiation source, which may cause
underdosing deep in the adventitia and geographical miss24 in
a radial sense rather than the more commonly described
longitudinal sense.
Radioactive Stent
The objective of using the radioactive stent is not to neutral-
ize myofibroblasts in the adventitia; it is the prevention of the
migration and invasion of myofibroblasts from the adventitia
through the stent struts and into the lumen. As is seen in the
HA group, this is accomplished by the continuous and low
dose rate provided by the radioactive stent. Because of the
range of the “radioactive fence” created, adventitial cells
remain intact without upregulation of growth factors and
inhibition of contractile proteins. Consequently, no remodel-
ing is seen behind the radioactive stent at either activity level.
Edge Remodeling
Hoffmann et al15 have previously described negative remod-
eling at the stent edge after conventional stent implantation.
In the present study, we have been able to precisely describe
the decrease in TVV as the dominant contributor to nonreste-
notic lumen loss at the stent edge. Recent reports on radio-
active stents suggest that the edge effect and edge restenosis
may be due to an increase in plaque at the edge and to a
component of negative remodeling as one moves axially from
the stent.4 The contributing factors to radioactive stent edge
restenosis have been discussed in detail recently by Serruys
and Kay.25
It may be argued that stent-edge restenosis was not seen in
the CBS group because no individuals with geographical miss
were evaluated. However, our objective in the present study
was to analyze the vascular response to appropriately applied
catheter-based radiation, which necessitates the exclusion of
all those in whom injury was not covered by radiation. Recent
reports have suggested that the combination of suboptimal
low-dose radiation and injury may make individuals with
geographical miss vulnerable to edge restenosis.26
Study Limitations
This was a retrospective nonrandomized study of individuals
who had completed 6 months of follow-up and in whom
IVUS examination was possible. Individuals who had a total
occlusion or in whom the IVUS catheter could not be passed
under acceptable clinical circumstances were not included.
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No edge restenosis was seen in the CBS group, unlike the
HA group; however, both the CBS and the HA groups
reflected the larger parent populations from which they were
selected in all other features.
The dosimetry (catheter-based) described in the present
study relates to prescribed doses only and does not necessar-
ily reflect the dose delivered 2 mm from the source in the
adventitia. Description of dosimetry is beyond the scope of
the present study; however, previous work by the authors
(Sabate´ et al27 ), who used a similar radiation source and
study population, suggests that delivered dose, residual
plaque burden, and tissue composition play a fundamental
role on the volumetric outcome at 6 months of follow-up after
catheter-based b-radiation therapy and BA.
Conclusions
Distinct differences in the patterns of remodeling exist
between conventional, radioactive, and catheter-based radio-
therapy with stenting. Users of radiation need to be alerted to
edge restenosis seen after higher activity radioactive stent
implantation and positive remodeling behind the stent seen
after catheter-based radiation and stenting. Radiation,
whether it be catheter or stent-based, has forced the interven-
tional community to look closely not only at effective
inhibition of intimal proliferation but also at the adverse
response of the artery to the combination of injury and
radiation.
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